G0 Function of BCL2 and BCL-xL Requires BAX, BAK, and p27 Phosphorylation by Mirk, Revealing a Novel Role of BAX and BAK in Quiescence Regulation
Open Access
- 1 December 2008
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (49) , 34108-34120
- https://doi.org/10.1074/jbc.m806294200
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Bcl-2-regulated apoptosis: mechanism and therapeutic potentialCurrent Opinion in Immunology, 2007
- Mirk/Dyrk1B in cancerJournal of Cellular Biochemistry, 2007
- Caspase-9 and effector caspases have sequential and distinct effects on mitochondriaOncogene, 2005
- Bcl-2 inhibition of T-cell proliferation is related to prolonged T-cell survivalOncogene, 2004
- Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificityNature Immunology, 2003
- BCL-xL and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinasesOncogene, 2002
- Bcl-2 Expression Inhibits Liver Carcinogenesis and Delays the Development of Proliferating FociThe American Journal of Pathology, 2002
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and DeathScience, 2001
- Loss of anti-mitotic effects of Bcl-2 with retention of anti-apoptotic activity during tumor progression in a mouse modelOncogene, 1999
- Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death.The Journal of Experimental Medicine, 1996